Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 1
2019 7
2020 372
Text availability
Article attribute
Article type
Publication date

Search Results

379 results
Results by year
Filters applied: . Clear all
Page 1
COVID-19: Melatonin as a potential adjuvant treatment.
Zhang R, Wang X, Ni L, Di X, Ma B, Niu S, Liu C, Reiter RJ. Zhang R, et al. Life Sci. 2020 Jun 1;250:117583. doi: 10.1016/j.lfs.2020.117583. Epub 2020 Mar 23. Life Sci. 2020. PMID: 32217117 Free PMC article. Review.
This article summarizes the likely benefits of melatonin in the attenuation of COVID-19 based on its putative pathogenesis. The recent outbreak of COVID-19 has become a pandemic with tens of thousands of infected patients. ...There is significant data …
This article summarizes the likely benefits of melatonin in the attenuation of COVID-19 based on its putative pathogenesis. Th …
A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19.
Cortegiani A, Ingoglia G, Ippolito M, Giarratano A, Einav S. Cortegiani A, et al. J Crit Care. 2020 Jun;57:279-283. doi: 10.1016/j.jcrc.2020.03.005. Epub 2020 Mar 10. J Crit Care. 2020. PMID: 32173110
PURPOSE: COVID-19 (coronavirus disease 2019) is a public health emergency of international concern. As of this time, there is no known effective pharmaceutical treatment, although it is much needed for patient contracting the severe form of the disease. The a …
PURPOSE: COVID-19 (coronavirus disease 2019) is a public health emergency of international concern. As of this time, there is …
Case of the Index Patient Who Caused Tertiary Transmission of COVID-19 Infection in Korea: the Application of Lopinavir/Ritonavir for the Treatment of COVID-19 Infected Pneumonia Monitored by Quantitative RT-PCR.
Lim J, Jeon S, Shin HY, Kim MJ, Seong YM, Lee WJ, Choe KW, Kang YM, Lee B, Park SJ. Lim J, et al. J Korean Med Sci. 2020 Feb 17;35(6):e79. doi: 10.3346/jkms.2020.35.e79. J Korean Med Sci. 2020. PMID: 32056407 Free PMC article.
Since mid-December of 2019, coronavirus disease 2019 (COVID-19) infection has been spreading from Wuhan, China. The confirmed COVID-19 patients in South Korea are those who came from or visited China. ...The 54-year old male is the third patient diagno …
Since mid-December of 2019, coronavirus disease 2019 (COVID-19) infection has been spreading from Wuhan, China. The confirmed …
Antiviral treatment of COVID-19.
Şimşek Yavuz S, Ünal S. Şimşek Yavuz S, et al. Turk J Med Sci. 2020 Apr 21;50(SI-1):611-619. doi: 10.3906/sag-2004-145. Turk J Med Sci. 2020. PMID: 32293834 Free PMC article. Review.
Currently, there is not any specific effective antiviral treatment for COVID-19. Although most of the COVID-19 patients have mild or moderate courses, up to 5%–10% can have severe, potentially life threatening course, there is an urgent need for …
Currently, there is not any specific effective antiviral treatment for COVID-19. Although most of the COVID-1
Traditional Chinese medicine for COVID-19 treatment.
Ren JL, Zhang AH, Wang XJ. Ren JL, et al. Pharmacol Res. 2020 May;155:104743. doi: 10.1016/j.phrs.2020.104743. Epub 2020 Mar 4. Pharmacol Res. 2020. PMID: 32145402 Free PMC article. No abstract available.
Treatment of COVID-19: old tricks for new challenges.
Cunningham AC, Goh HP, Koh D. Cunningham AC, et al. Crit Care. 2020 Mar 16;24(1):91. doi: 10.1186/s13054-020-2818-6. Crit Care. 2020. PMID: 32178711 Free PMC article. No abstract available.
The epidemiology, diagnosis and treatment of COVID-19.
Zhai P, Ding Y, Wu X, Long J, Zhong Y, Li Y. Zhai P, et al. Int J Antimicrob Agents. 2020 May;55(5):105955. doi: 10.1016/j.ijantimicag.2020.105955. Epub 2020 Mar 28. Int J Antimicrob Agents. 2020. PMID: 32234468 Free PMC article.
This paper reviews the literature on all available information about the epidemiology, diagnosis, isolation and treatments of COVID-19. ...In addition, registered trials investigating treatment options for COVID-19 infection are listed....
This paper reviews the literature on all available information about the epidemiology, diagnosis, isolation and treatments of COVID- …
The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China.
Zhang W, Zhao Y, Zhang F, Wang Q, Li T, Liu Z, Wang J, Qin Y, Zhang X, Yan X, Zeng X, Zhang S. Zhang W, et al. Clin Immunol. 2020 May;214:108393. doi: 10.1016/j.clim.2020.108393. Epub 2020 Mar 25. Clin Immunol. 2020. PMID: 32222466 Free PMC article. Review.
The pandemic outbreak of coronavirus disease 2019 (COVID-19) is rapidly spreading all over the world. Reports from China showed that about 20% of patients developed severe disease, resulting in a fatality of 4%. ...Here, from the perspective of clinical immunologist …
The pandemic outbreak of coronavirus disease 2019 (COVID-19) is rapidly spreading all over the world. Reports from China showe …
Update on treatment of COVID-19: ongoing studies between promising and disappointing results.
Esposito S, Noviello S, Pagliano P. Esposito S, et al. Infez Med. 2020 Ahead of print Jun 1;28(2):198-211. Infez Med. 2020. PMID: 32335561 Free article. Review.
The COVID-19 pandemic represents the greatest global public health crisis since the pandemic influenza outbreak of 1918. We are facing a new virus, so several antiviral agents previously used to treat other coronavirus infections such as SARS and MERS are being cons …
The COVID-19 pandemic represents the greatest global public health crisis since the pandemic influenza outbreak of 1918. We ar …
Efficacy of chloroquine and hydroxychloroquine in the treatment of COVID-19.
Meo SA, Klonoff DC, Akram J. Meo SA, et al. Eur Rev Med Pharmacol Sci. 2020 Apr;24(8):4539-4547. doi: 10.26355/eurrev_202004_21038. Eur Rev Med Pharmacol Sci. 2020. PMID: 32373993 Free article. Review.
The aim of this study was to indirectly investigate the efficacy of chloroquine and hydroxychloroquine for the treatment of COVID-19 by determining the prevalence of COVID-19 in malaria pandemic and non-pandemic nations. ...The search was based …
The aim of this study was to indirectly investigate the efficacy of chloroquine and hydroxychloroquine for the treatment of COVID
379 results
Jump to page
Feedback